Clinical Trial

A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will be conducted to compare Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2025-02-06; most recent amendment 2026-03-19.
Status change: Recruiting → Active, Not Recruiting 2025-09-04
Status change: Not Yet Recruiting → Recruiting 2025-05-16
Trial Details
NCT Number NCT06821542
Lead Sponsor Incyte Corporation
Conditions Chronic Graft-versus-host-disease
Enrollment 9 participants
Start Date 2025-06-04
Primary Completion 2028-05-31 (estimated)
Study Completion 2032-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-23